Filing Flows

Filing Flows › ImmunityBio (IBRX) › Who owns the stock

Who owns ImmunityBio (IBRX) stock

380 funds reported ImmunityBio (IBRX) shares in their latest 13F filings, worth $1.8B in all. The largest holder is BlackRock ($298M). Last quarter 177 funds added to their stakes and 131 cut them. Members of Congress and other officials disclosed 2 trades (2 buys, 0 sales).

Largest holders of IBRX (13F)Largest holders of IBRX (13F)BlackRock$298MState Street$187MVanguard Portfolio Management LLC$156MVanguard Capital Management LLC$137MD. E. Shaw$101MTwo Sigma Investments, LP$97.2MGeode Capital Management, LLC$86.2MVanguard Group$64.9MMillennium Management LLC$48.9MNorthern Trust$31.2M

Largest holders (13F)

FundSharesValueChangeQuarter
BlackRock34,083,262$298Mincrease2026-06-30
State Street21,398,438$187Mincrease2026-06-30
Vanguard Portfolio Management LLC17,863,911$156Mincrease2026-06-30
Vanguard Capital Management LLC15,691,579$137Mincrease2026-06-30
D. E. Shaw11,551,019$101Mdecrease2026-06-30
Two Sigma Investments, LP11,097,106$97.2Mincrease2026-06-30
Geode Capital Management, LLC9,847,896$86.2Mincrease2026-06-30
Vanguard Group32,777,257$64.9Mincrease2025-12-31
Millennium Management LLC5,579,793$48.9Mincrease2026-06-30
Northern Trust3,565,248$31.2Mincrease2026-06-30
Morgan Stanley3,432,678$30.1Mdecrease2026-06-30
Goldman Sachs Group3,234,277$28.3Mdecrease2026-06-30
UBS Group AG3,195,728$28.0Mincrease2026-06-30
Charles Schwab Investment Management2,888,607$25.3Mincrease2026-06-30
Woodline Partners LP2,500,189$21.9Mdecrease2026-06-30

Trades by Congress and other officials

DateWhoTradeAmount
2026-09-30Lisa McClainpurchase$1K–$15K
2026-09-28Lisa McClainpurchase$1K–$15K

ImmunityBio's latest quarter

ImmunityBio, Q2 2026: revenue $51.2M (+94% year over year), operating margin -120.4%, net loss $230M, operating cash flow −$66.5M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most IBRX stock?

By the latest 13F filings: BlackRock ($298M); State Street ($187M); Vanguard Portfolio Management LLC ($156M); Vanguard Capital Management LLC ($137M); D. E. Shaw ($101M).

Has Congress traded IBRX stock?

Officials disclosed 2 trades on file: 2 buys and 0 sales. The latest: Lisa McClain, purchase on 2026-09-30.

What is the short interest in IBRX?

122,945,839 shares were sold short at the 2026-10-15 settlement, -0.92% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.